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An Economical Method for the Continuous Production of Iodine-123 
A relatively simple and inexpensive method has 
been developed for producing the radioactive iodine 
isotope, iodine-l23, in a conventional cyclotron. 
Iodine-123 is a more desirable radioactive material 
for medical diagnoses than is the more available, and 
hence more commonly used, iodine-131. The shorter 
half-life and lower gamma ray energy (159 keV) of the 
123 isotope reduces a patient's radiation exposure to 
less than 3 percent of that normally acquired with the 
131 isotope. 
The method for producing iodine-123 utilizes tel-
lurium-122, a stable isotope available in enrichments 
exceeding 95 percent. The tellurium is held on a por-
ous metal plate by a flowing stream of helium and 
bombarded with either alpha particles or helium-3 in 
a conventional cyclotron. Nuclear reactions produce 
xenon-123 plus other contaminating radioactive ma-
terials of which iodine-124, iodine-125, and iodine-126 
are the most serious. The reaction products are con-
tinuously removed from the target by the flowing gas 
stream. The desirable iodine isotopes are removed by 
cooling the gas stream to dry ice temperature 
(-78 0 C) at which point these isotopes condense. Fur-
ther cooling the gas stream to liquid nitrogen tempera-
tures condenses the xenon-123 to permit its removal. 
Radioactive decay of the xenon produces iodine-123 
in 4 to 8 hours.
Notes: 
I. Small cyclotrons are being increasingly used in the 
medical field to produce medical radioisotopes. A 
30 MeV helium-3 beam produced by such commer-
cially available cyclotrons is ideal for the produc-
tion method described above. 
2. lodine-123 has been produced by other methods; 
however, the method described above produces the 
highest ratio of this isotope relative to other radio-
active iodine isotopes that may remain in the 
product. 
3. No additional documentation is available. Ques-
tions may be directed to: 
Technology Utilization Officer 
Lewis Research Center 
21000 Brookpark Road 
Cleveland, Ohio 44135 
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